biotech insider sells Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : biotech insider sells

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: dalroi who started this subject	1/12/2004 8:38:13 AM
From: nigel bates	Read Replies (1) of 32

XOMA Executives to Enter Into Rule 10b5-1 Selling Plans Monday January 12, 7:31 am ET BERKELEY, Calif.--(BUSINESS WIRE)--Jan. 12, 2004--XOMA Ltd. (Nasdaq:XOMA - News) today announced that up to three of its executives, including its Chief Executive Officer, may adopt prearranged trading plans in accordance with guidelines specified by Rule 10b5-1 under the Securities Exchange Act of 1934 and the company's policies with respect to insider sales. Rule 10b5-1 allows officers and directors of public companies, at a time when they are not aware of material nonpublic information, to adopt predetermined plans for selling shares. Under these 10b5-1 plans, each executive will be limited to the sale of the number of common shares represented by share options held by the executive that would otherwise expire in January and February of 2005. In total, up to approximately 675,000 common shares may be sold under these plans. These sales may take place from time to time and may be subject to various market conditions. Each executive's plan will be separate and unrelated to the others.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next